Aptevo Therapeutics Inc.
APVO
$1.55
$0.1510.71%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 16.66% | -79.13% | -48.45% | -59.43% | -61.60% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 99.12% | 18.98% | 14.66% | 19.60% | -12.31% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -88.53% | -82.63% | -62.84% | -3.85% | -6.41% |
| Total Current Assets | 15.68% | -70.13% | -44.09% | -52.61% | -57.76% |
|
|
|||||
| Total Current Assets | 15.68% | -70.13% | -44.09% | -52.61% | -57.76% |
| Net Property, Plant & Equipment | -14.96% | -14.76% | -14.61% | -14.48% | -14.28% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 4.71% | -52.68% | -37.24% | -44.17% | -48.39% |
|
|
|||||
| Total Accounts Payable | -22.30% | 1.85% | -23.37% | -11.70% | -23.33% |
| Total Accrued Expenses | 16.59% | -70.68% | -11.53% | -39.54% | -30.96% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 941.76% | 322.39% | -53.68% | -44.47% | -87.80% |
| Total Other Current Liabilities | 941.76% | 322.39% | -53.68% | -44.47% | -87.80% |
| Total Current Liabilities | -9.74% | -14.37% | -14.08% | -13.96% | -21.59% |
|
|
|||||
| Total Current Liabilities | -9.74% | -14.37% | -14.08% | -13.96% | -21.59% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -16.24% | -15.19% | -14.23% | -13.36% | -12.58% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -12.99% | -14.84% | -14.14% | -13.58% | -17.39% |
|
|
|||||
| Common Stock & APIC | 10.84% | 6.82% | 7.07% | 5.78% | 5.79% |
| Retained Earnings | -10.17% | -10.29% | -10.80% | -10.90% | -11.81% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 46.18% | -124.14% | -61.09% | -69.97% | -72.54% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 46.18% | -124.14% | -61.09% | -69.97% | -72.54% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 46.18% | -124.14% | -61.09% | -69.97% | -72.54% |
|
|
|||||